Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials

We studied the ASBMT 6 month (m) freedom from treatment failure (FFTF) as a predictor of survival for patients with acute graft-versus-host disease (aGVHD) requiring treatment. Adult patients undergoing allogeneic hematopoietic cell transplant (HCT) from February 2007 to March 2009 who were enrolled...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sengsayadeth, Salyka, Savani, Bipin N., Jagasia, Madan, Goodman, Stacey, Greer, John P., Chen, Heidi, Chinratanalab, Wichai, Kassim, Adetola A., Engelhardt, Brian G.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3946331/
https://ncbi.nlm.nih.gov/pubmed/24096824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2013.157
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items